CSIMarket
 


Celgene Corp  (CELG)
Other Ticker:  
 
 

CELG's Net Cash Flow Growth by Quarter and Year

Celgene's Net Cash Flow results by quarter and year




CELG Net Cash Flow (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 1,754.00 1,502.00 647.30
III Quarter September 2,390.00 977.00 -1,149.00 458.90
II Quarter June 1,781.00 -1,316.00 1,387.00 618.20
I Quarter March 1,199.00 -4,194.00 -897.00 -434.80
FY   5,370.00 -2,779.00 843.00 1,289.60



CELG Net Cash Flow third quarter 2019 Y/Y Growth Comment
Celgene Corp achieved in the third quarter, above Company average Net Cash Flow surge of 144.63% year on year, to $ 2,390.00 millions.

Among companies who have reported third quarter results in the Major Pharmaceutical Preparations industry only one Company has achieved higher year on year Net Cash Flow results in the third quarter. While Celgene Corp' s Net Cash Flow doubling of 144.63% ranks overall at the positon no. 79 in the third quarter.




CELG Net Cash Flow ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - 16.78 % 132.04 % -
III Quarter September 144.63 % - - -66.9 %
II Quarter June - - 124.36 % 279.03 %
I Quarter March - - - -
FY   - - -34.63 % 95.52 %

Financial Statements
Celgene's third quarter 2019 Net Cash Flow $ 2,390.00 millions CELG's Income Statement
Celgene's third quarter 2018 Net Cash Flow $ 977.00 millions Quarterly CELG's Income Statement
New: More CELG's historic Net Cash Flow Growth >>


CELG Net Cash Flow (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - 79.53 % - 41.05 %
III Quarter September 34.19 % - - -25.77 %
II Quarter June 48.54 % - - -
I Quarter March -31.64 % - - -
FY (Year on Year)   - - -34.63 % 95.52 %




Net Cash Flow third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #7
Overall #79

Net Cash Flow Y/Y Growth Statistics
High Average Low
749.48 % 63.63 % -95.38 %
(Dec. 31, 2006)   (Sep. 30, 2007)
Net Cash Flow third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #7
Overall #79
Net Cash Flow Y/Y Growth Statistics
High Average Low
749.48 % 63.63 % -95.38 %
(Dec. 31, 2006)   (Sep. 30, 2007)

Net Cash Flow by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Celgene's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
60229.21 % 2383.35 % -100 %
(Sep. 30, 2012)  


CELG's III. Quarter Q/Q Net Cash Flow Comment
Celgene Corp achieved in the III. Quarter 2019 below company average Net Cash Flow jump of 34.19% quarter on quarter, to $ 2,390.00 millions.

Even if the III. Quarter 2019 results were beneath the average of 2383.35 %, this has been yet promising news, as the III. Quarter expension, eclipses the % Net Cash Flow growth in the III. Quarter 2018

Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Celgene's Net Cash Flow growth quarter on quarter, overall rank is 180.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #5
Healthcare Sector #23
Overall #180
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #5
Healthcare Sector #23
Overall #180
Net Cash Flow Q/Q Growth Statistics
High Average Low
60229.21 % 2383.35 % -100 %
(Sep. 30, 2012)  


CELG's III. Quarter Q/Q Net Cash Flow Comment
Celgene Corp achieved in the III. Quarter 2019 below company average Net Cash Flow jump of 34.19% quarter on quarter, to $ 2,390.00 millions.

III. Quarter 2019 Celgene's performance were contradictory, albeit lower than the regular increase of 2383.35 %, yet it demonstrates real recovery compare to the % in the III. Quarter 2018 María Carmen Pérez, Healthcare sector researcher said.

Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Celgene's Net Cash Flow growth quarter on quarter, overall rank is 180.


Celgene's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
Cumulative Net Cash Flow 12 Months Ending $ 7,124.00 $ 5,711.00 $ 2,614.00 $ -2,779.00 $ -3,031.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) 24.74 % 118.48 % - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 312 # 146 # 0 # 0 # 0




Cumulative Net Cash Flow growth Comment
Celgene saw improvement in Net Cash Flow growth trend, posting cumulative 12 months Net Cash Flow growth of 144.63% year on year, to $ 7,124 millions if the fiscal year would have ended in Sep 30 2019.
Celgene's trailing twelve months Net Cash Flow growth was higher than company's average 105.24% and higher than % growth in Jun 30 2019. And, Celgene realized the fastest Net Cash Flow growth, in Major Pharmaceutical Preparations industry.
But sequential growth rate was slower at 24.74 % from $5711 millions achieved in twelve months ending a quarter before.
There is slowdown in progress, more obvious if you pay attention to the typical Q/Q TTM historic increase which is better at63.63% María Carmen Pérez published. In the Sep 30 2019 period, Celgene had cumulative twelve months Net Cash Flow of $ 7,124 millions compare to net cash outflow of $ -3,031 millions a year ago.

Celgene Corp achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
749.48 %
63.63 %
-95.38 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
963.5 %
105.24 %
-96.05 %
(Mar 31 2017)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 36
S&P 500 # 312
Cumulative Net Cash Flow growth Comment
Celgene saw improvement in Net Cash Flow growth trend, posting cumulative 12 months Net Cash Flow growth of 144.63% year on year, to $ 7,124 millions if the fiscal year would have ended in Sep 30 2019.
Celgene's trailing twelve months Net Cash Flow growth was higher than company's average 105.24% and higher than % growth in Jun 30 2019. And, Celgene realized the fastest Net Cash Flow growth, in Major Pharmaceutical Preparations industry.
But from the previous reporting period growth rate was beneth at 24.74 % from $5711 millions recorded in the period from Jun 30 2019 to Sep 30 2018 María Carmen Pérez added on.
It appears to be stagnation developing, more noticeable if you pay attention to the usual sequential Net Cash Flow increase that is higher at 63.63% María Carmen Pérez wrote.
The momentum was much stronger from the previous reporting period showed at 24.74 % jump from $5711 millions in twelve months ending a quarter Jun 30 2019. In the Sep 30 2019 period, Celgene had cumulative twelve months Net Cash Flow of $ 7,124 millions compare to net cash outflow of $ -3,031 millions a year ago.

Celgene Corp achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
749.48 %
63.63 %
-95.38 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
963.5 %
105.24 %
-96.05 %
(Mar 31 2017)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 36
S&P 500 # 312




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
CELG's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for CELG's Competitors
Net Cash Flow Growth for Celgene's Suppliers
Net Cash Flow Growth for CELG's Customers

You may also want to know
CELG's Annual Growth Rates CELG's Profitability Ratios CELG's Asset Turnover Ratio CELG's Dividend Growth
CELG's Roe CELG's Valuation Ratios CELG's Financial Strength Ratios CELG's Dividend Payout Ratio
CELG's Roa CELG's Inventory Turnover Ratio CELG's Growth Rates CELG's Dividend Comparisons



Companies with similar Net Cash Flow jump for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2019
Harvard Bioscience Inc212.34%$ 212.343 millions
Integra Lifesciences Holdings Corp211.17%$ 211.175 millions
Cumberland Pharmaceuticals Inc156.20%$ 156.197 millions
Icu Medical Inc147.78%$ 147.783 millions
Amgen Inc 144.93%$ 144.932 millions
Celgene Corp144.63%$ 144.626 millions
Hologic Inc90.47%$ 90.471 millions
Skinvisible Inc 87.86%$ 87.858 millions
Redhawk Holdings Corp 87.27%$ 87.265 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FELE's Profile

Stock Price

FELE's Financials

Business Description

Fundamentals

Charts & Quotes

FELE's News

Suppliers

FELE's Competitors

Customers & Markets

Economic Indicators

FELE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071